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AbsTrACT
Objectives To report investigations performed in 
children with progressive neurodegenerative diseases 
reported to this UK study.
Design Since 1997 paediatric surveillance for variant 
Creutzfeldt-Jakob disease (vCJD) has been performed 
by identifying children aged less than 16 years with 
progressive intellectual and neurological deterioration 
(PIND) and searching for vCJD among them.
setting The PIND Study obtains case details from 
paediatricians who notify via the British Paediatric 
Surveillance Unit.
Participants Between May 1997 and October 2017, 
a total of 2050 cases meeting PIND criteria had been 
notified and investigated.
results Six children had vCJD. 1819 children had other 
diagnoses, made in 12 cases by antemortem brain biopsy 
and in 15 by postmortem investigations. 225 children 
were undiagnosed: only 3 had antemortem brain 
biopsies and only 14 of the 108 who died were known 
to have had autopsies; postmortem neuropathological 
studies were carried out in just 10% (11/108) and only 
two had prion protein staining of brain tissue. Of the 
undiagnosed cases 43% were known to come from 
Asian British families.
Conclusions Most of the notified children had a 
diagnosis other than vCJD to explain their neurological 
deterioration. None of the undiagnosed cases had 
the clinical phenotype of vCJD but brain tissue was 
rarely studied to exclude vCJD. Clinical surveillance via 
the PIND Study remains the only practical means of 
searching for vCJD in UK children.
InTrODuCTIOn
The first cases of variant Creutzfeldt-Jakob disease 
(vCJD) in young adults were reported by the 
National Creutzfeldt-Jakob Disease Research and 
Surveillance Unit (NCJDRSU) in 1996.1 Until 2016, 
all the 177 definite and probable cases of vCJD2 had 
occurred in patients who were methionine homozy-
gous (MM) at codon 129 of the prion protein gene 
(PRNP). However, in January 2017, it was reported 
that vCJD had been confirmed in a man who was 
methionine/valine (MV) heterozygous at PRNP 
codon 129.3 In the general population of the UK 
about 44% have the MM genotype and 45% are 
MV,4 which raises the possibility of a second wave 
of vCJD cases in those with the MV genotype. In 
addition, there are concerns about surgical5 and 
bloodborne transmission,6 so there is a need for 
continuing national surveillance for vCJD.
When vCJD was reported in adults it raised the 
possibility that it might occur in children and it 
was therefore necessary to search systematically for 
cases of vCJD among the many neurodegenerative 
disorders of childhood. In 1997, the PIND Study 
commenced via the British Paediatric Surveillance 
Unit (BPSU). Paediatricians in the UK are asked 
to notify all patients aged less than 16 years with 
‘progressive intellectual and neurological deteriora-
tion’ (PIND) because this group of children is likely 
to include any cases of vCJD.
Most of the children notified to the PIND Study 
have an underlying diagnosis other than vCJD to 
explain their deterioration. However, vCJD could 
be hidden among undiagnosed cases. This paper 
considers the public health issues raised by this 
undiagnosed group, including an analysis of any 
differences according to patient ethnicity as there 
What is already known on this topic?
 ► Since 1997, the PIND Study has identified six 
UK children with variant Creutzfeldt-Jakob 
disease (vCJD).
 ► In 2017, vCJD was reported in a man who was 
methionine/valine (MV) heterozygous at PRNP 
codon 129.
 ►  This novel finding raises the possibility of a 
second wave of vCJD cases in UK individuals 
with the MV genotype.
What this study adds?
 ► Most of the Study children had a 
diagnosis other than vCJD to explain their 
neurological deterioration but some of them 
remained undiagnosed even after death.
 ► Of the 225 undiagnosed PIND children, only 
10% of those who died had postmortem 
neuropathological studies; only 2 had prion 
protein staining of brain tissue.
 ►  The low autopsy rate in undiagnosed children 
emphasises the need to obtain antemortem 
or postmortem samples of blood and other 
relevant tissues for later study.
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are relatively large numbers of PIND cases in certain ethnic 
groups.7
MeThODs
The BPSU has studied rare childhood disorders since 1986.8 
All UK consultant paediatricians are requested to notify chil-
dren with conditions under surveillance using a monthly online 
system. Currently 3580 paediatricians are involved and over 
90% reply. The PIND Study has used the BPSU system since 
1997,9 asking for notifications of all children meeting the case 
definition for PIND shown in box 1 (see the protocol in the 
BPSU section of the Royal College of Paediatrics and Child 
Health website10).
Clinical information is obtained via a questionnaire completed 
by the notifying paediatrician, via telephone interview or by site 
visit; there is no contact with the patients or their families. The 
study records information about presenting symptoms and signs 
and follows progress after presentation.
Classification of ethnicity is that used by the then Communi-
cable Disease Surveillance Centre, Colindale, London, UK, when 
the PIND Study commenced in 1997. The categories are: White, 
Black, Indian, Pakistani, Bangladeshi, Chinese and Other. Some 
clinicians reported that their patients were ‘Asian unspecified’. 
For the current analysis the categories Indian, Pakistani, Bangla-
deshi, Chinese and ‘Asian unspecified’ were combined under the 
heading ‘Asian British’ for comparison with the 2011 census of 
England and Wales where these groups were combined as ‘Asian/
Asian British’.11 The PIND questionnaire asks if the parents of 
notified children are consanguineous, without defining the term, 
but the details were obtained and only close blood relatives (ie, 
cousins) were included in this group.
The clinical data are anonymised by the PIND Study team 
and are then reviewed by an independent PIND Expert Group 
to confirm and classify diagnoses. The Group consists of paedi-
atric neurologists, specialists in paediatric metabolic disease and 
representatives from the NCJDRSU. If vCJD is suspected it is 
suggested that the local paediatrician obtains consent to refer 
the child to the NCJDRSU in Edinburgh. Otherwise, the notified 
children are followed up by the PIND team via the local clinician 
until: (A) a definite diagnosis is made, (B) no further investi-
gations are planned, or (C) the child dies. These children are 
often investigated by several national or international experts. 
Some remain undiagnosed despite all investigations; they are not 
systematically followed up by the PIND Study, however the noti-
fying paediatricians are asked to inform the Study if a diagnosis 
is subsequently made.
For this paper, an autopsy is defined as: ‘dissection and system-
atic examination of a body after death in order to determine the 
cause of death or the presence of disease processes’. The term 
‘post-mortem pathological examination’ is used to include full 
autopsies as well as more limited postmortem examinations or 
biopsies of one or more tissues after death.
Consent for research was granted by Addenbrooke’s 
Cambridgeshire 2 Research Ethics Committee (Ref: 97/010); 
Patient Information Advisory Group/BPSU 2-10(c)(2005), 
National Information Governance Board, and Confidentiality 
Advisory Group under Section 251 of the National Health Service 
(NHS) Act 2006. Sponsored by Cambridge University Hospitals 
NHS Foundation Trust, R&D reference A05001. Registered on 
the National Research Register (ID N0287023055). UKCRN ID 
6636.
resulTs
Between May 1997 and October 2017, a total of 4244 children 
had been notified to the PIND Study. Of these, 1933 were found 
not to meet the PIND criteria and 261 were either still under 
investigation or clinical details were pending. The other 2050 
cases met the PIND criteria and had been fully investigated; 6 
had vCJD (identified between 1997 and 2000)9 12 and 1819 
(89% of the PIND cases) had a diagnosis other than vCJD to 
explain their deterioration. In the remaining 225 children (11% 
of the PIND cases) investigations had been negative or they had 
died undiagnosed.
The 1819 diagnosed cases
In the diagnosed group 977 were male, 842 were female; the 
ethnic distribution is shown in figure 1. The proportion of Asian 
British families in the diagnosed group was 29% (483/1683 for 
whom ethnicity was known). The rate of consanguinity in the 
diagnosed group was 32% (461/1440 for whom consanguinity 
was known). The 483 Asian British children comprised: 327 
Pakistani, 43 Indian, 43 Bangladeshi, 5 Chinese and 65 Asian 
unspecified. The rate of consanguinity in the families of Paki-
stani origin was 85% (279/327). In the whole diagnosed group 
there were more than 190 different disorders; figure 2 shows the 
10 disorders identified most frequently.
In 13 cases a brain biopsy had been performed during life 
and 12 helped to make the diagnosis. Of the diagnosed children 
241 were reported to have died; information about postmortem 
examinations was available for 109. Twenty-four of 109 (22%) 
had postmortem examinations of whom 20 had postmortem 
neuropathology (17 full autopsies, 1 coroner’s case without 
neuropathology, 3 limited to brain and spinal cord pathology, 
1 limited to biopsies of skin, muscle and liver, 1 liver biopsy 
only and 1 muscle biopsy only). Of the 24 postmortem studies 
15 helped to make the diagnosis and nine did not. Thus, the 
diagnosis was made without information from brain biopsies 
or postmortem examinations in 1819 − (12+15)=1792 cases 
(99%). The percentages known to have had postmortems by 
ethnic group were: White 21/1104=2%, Pakistani 2/327=1% 
box 1 Case definition—progressive intellectual and 
neurological deterioration
Any child (under 16 years of age at onset of symptoms) who fulfils 
all of the following three criteria:
 ► Progressive deterioration for more than 3 months.
 ► Loss of already attained intellectual or developmental 
abilities. 
 ► Development of abnormal neurological signs.
excluding:
 ► Static intellectual loss, for example, after encephalitis, head 
injury or near drowning.
Including:
 ► Children who meet the case definition, even if specific 
neurological diagnoses have been made.
 ► Metabolic disorders leading to neurological deterioration.
 ► Seizure disorders if associated with progressive deterioration.
 ► Children who have been diagnosed as having 
neurodegenerative disorders who have not yet developed 
symptoms.
Reporting restricted to cases seen in the last month but including 
those whose condition began earlier (ie, including ‘old cases’ of 
children in follow-up if seen in that month).
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and Indian 1/43=2%. The last reported diagnostic postmortem 
was in 2007.
The 225 undiagnosed cases
In the undiagnosed group 118 were male, 107 were female; 
the ethnic distribution is shown in figure 1. There was a high 
rate of consanguinity—52% of those for whom the data were 
available (100/194). The proportion of Asian British families in 
the undiagnosed group was 43% (94 of 217 for whom ethnicity 
was known). The 94 Asian British children comprised: 72 Paki-
stani, 7 Indian, 4 Bangladeshi and 11 Asian unspecified. The 
rate of consanguinity in the families of Pakistani origin was 89% 
(64/72), compared with 7% (8/108) in the White families.
The 225 undiagnosed cases had usually been very thoroughly 
investigated with, where appropriate, metabolic tests, neuro-
physiological studies, brain scans, karyotyping, DNA studies, 
skin, muscle and rectal biopsies as shown in table 1.
CT brain scans were performed in 65/223 (29%) (2: infor-
mation not available) and at least one MRI brain scan was 
performed in 184/224 (82%) (1: information not available). 
Figure 1 Flow chart showing the ethnicity of the 2050 cases that met 
the PIND criteria and had been fully investigated. *Proportion for whom 
ethnicity was known. F, female; M, male; PIND, progressive intellectual 
and neurological deterioration; vCJD, variant Creutzfeldt-Jakob disease. 
Figure 2 The 10 most common diagnoses of more than 190 different 
disorders in the 1819 diagnosed children with progressive intellectual 
and neurological deterioration identified between May 1997 and 
October 2017. ALD, adrenoleukodystrophy; Krabbe, Krabbe disease; 
MLD, metachromatic leukodystrophy; MPS III, mucopolysaccharidosis 
type III; NCL, neuronal ceroid lipofuscinosis; NP-C, Niemann-Pick disease 
type C; Rett, Rett syndrome; Sandhoff, Sandhoff disease; Tay-Sachs, Tay-
Sachs disease.
Table 1 Specialised investigations reported in the 225 undiagnosed 
cases during life, in addition to extensive biochemical studies of blood 
and urine
Investigation Cases (n)
MRI brain scans 184
Electroencephalogram 159
Cerebrospinal fluid examination 115 (85 for lactate level)
White cell lysosomal enzyme study 89
Electroretinogram±visual evoked potentials 74
CT brain scans 65
DNA studies for known mutations 49 (23 of these for known
mitochondrial disorders)
Muscle biopsy 46
Skin biopsy (often for culture of skin fibroblasts) 31
Nerve conduction study±electromyography 27
Chromosomes 18
Bone marrow for histology 6
Rectal biopsy 5
Brain biopsy 3
Conjunctival biopsy 2
Liver biopsy 1
Table 2 Principal abnormalities reported on CT and MRI brain scans 
in the 225 undiagnosed cases
Principal abnormality CT brain scans MrI brain scans
Normal 28 45
Cerebral atrophy 20 33
Cerebellar atrophy 1 9
Generalised atrophy 3 32
White matter abnormalities – 25
Basal ganglia changes 5 8
Intracranial calcification 5 – 
Periventricular low intensity 1 – 
Mixed (atrophy plus white matter 
abnormalities)
– 24
Other* – 7
No result 2 1
Total 65 184
Forty-nine children had both CT and MRI scans, so there was overlap in the findings 
on the scans.
Brainstem abnormalities reported on MRI scans: small/atrophic 6, signal 
abnormalities 2. None of these findings were reported as the principal abnormality 
on the relevant scan so these cases are included in the numbers shown in the table.
*Partial callosal agenesis, microcephaly, ventriculomegaly, hypoplastic optic chiasm, 
right hemiatrophy, multiple small infarcts, arteriovenous malformation. 
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The principal abnormalities found on these scans were heteroge-
neous (see table 2).
It was reassuring that none of the MRI scans were reported to 
have the pulvinar sign associated with vCJD.13 MRI brain scans 
were performed in 73/94 (78%) of the Asian British children 
compared with 92/108 (85%) of the White children, suggesting 
that Asian British children were being as thoroughly investigated 
as White children because MRI scans are not easily performed 
in this age group.
In three undiagnosed children a brain biopsy had been 
performed during life. In 123 cases the child’s death had been 
reported. Postmortem pathological examinations had been 
carried out in 14 (13%) of the 108 cases for whom informa-
tion was available: 9 had a full autopsy and 5 had partial exam-
inations (in 1 the brain was not examined, in 2 just the brain 
was examined, in 1 postmortem liver and muscle biopsies were 
taken and 1 had a postmortem liver biopsy). Postmortem neuro-
pathological examination was carried out in 11 cases, in two of 
these brain tissue was sent to the NCJDRSU where staining for 
abnormal prion protein was negative. In another case, the neuro-
pathology was reviewed by the NCJDRSU and was not that of 
vCJD. In the ethnic groups the percentages that had postmor-
tems were: White 8/108=7%, Pakistani 4/72=6% and Indian 
2/7=29%.
Children were not routinely followed by the Study after being 
allocated to the undiagnosed group. Therefore, in October 2017, 
the National Health Service Spine Portal was used to discover 
how many of the 225 undiagnosed cases had died by that time: 
the total number was 161, which is 38 cases more than had been 
reported by the notifying paediatricians between May 1997 and 
October 2017.
DIsCussIOn
Principal findings
Postmortems and diagnosis
The diagnosis was made without brain biopsy or postmortem 
neuropathology in 99% of the whole diagnosed group of chil-
dren with PIND. Only 24 children in the diagnosed group were 
known to have had postmortem examinations. However, these 
did help to make the diagnosis in 15 cases. It is therefore a 
concern that only 14 of the 108 undiagnosed children who died 
were known to have had postmortem studies and in three of 
these the brain was not examined.
Falling autopsy rates have been noted in adults and chil-
dren.14–16 Burton and Underwood14 reported that the overall 
autopsy rate in the UK in 1979 was 42.7%, falling to 15.3% 
in 2001. In 2015, Turnbull et al17 found that the mean autopsy 
rate in the UK was 0.69%: hospital autopsy rates in children’s 
hospital NHS trusts ranged from 0% to 21%. A recent systematic 
review18 of postmortem examinations in perinatal and paediatric 
settings stated, ‘…PM examinations result in clinically signifi-
cant findings in 22%–76% of cases…’
Possible hidden vCJD
It is reassuring that the majority of notified UK children who met 
the PIND criteria had a diagnosis other than vCJD to explain 
their deterioration. However, 225 of them had no diagnosis—
could some of them have vCJD? A previous short report by the 
PIND Study19 provided reassurance about this and the current 
data reinforce the view that there is no evidence of hidden vCJD 
in undiagnosed children with PIND; none fulfilled the sensi-
tive and specific diagnostic criteria for ‘probable’ vCJD (see 
table 3).20
However, it is a concern that prion protein staining of brain 
tissue was carried out in just two of the undiagnosed cases as this 
is the only way to completely exclude the diagnosis of vCJD.21 
Blood and urine tests for diagnosing vCJD have been developed, 
but are not sufficiently validated for routine clinical use.22–24
Ethnicity and consanguinity
The PIND Study has reported that the greatest numbers of cases 
come from areas where there are relatively large populations of 
Pakistani origin.7 These new data confirm that a large proportion 
of Study children are Asian British (29% in the diagnosed group 
and 43% in the undiagnosed group compared with 7.5% in the 
general population of England and Wales in 201111). There were 
high rates of consanguinity—in the families of undiagnosed chil-
dren of Pakistani origin with PIND it was 89%: possibly they 
have inherited neurodegenerative diseases that have not yet been 
characterised. These diseases may become evident as new diag-
nostic investigations are available.
Strengths and weaknesses of the PIND Study
The Study uses the well-established health surveillance mech-
anism of the BPSU.8 The PIND Study Expert Group includes 
representatives from the NCJDRSU and provides an indepen-
dent opinion about the diagnosis in every reported case. There 
is multisource ascertainment and the reporting is not restricted 
to cases admitted to hospital. The Study has confirmed the diag-
nosis of more than 190 known neurological disorders and has 
published case series of the diagnosed groups.25–28
Table 3 Current diagnostic criteria for vCJD as reported by Heath  
et al20 in 2010
subsection Item Criterion
I A Progressive neuropsychiatric disorder
B Duration of illness >6 months
C Routine investigations do not suggest an alternative 
diagnosis
D No history of potential iatrogenic exposure
E No evidence of a familial form of TSE
II A Early psychiatric features*
B Persistent painful sensory symptoms†
C Ataxia
D Myoclonus or chorea or dystonia
E Dementia
III A EEG does not show the typical appearance of sporadic CJD‡ 
in the early stages of illness
B Bilateral pulvinar high signal on MRI scan
IV A Positive tonsil biopsy§
Definite IA and neuropathological confirmation of vCJD ¶
Probable I and 4/5 of II and IIIA and IIIB; or I and IVA
Possible I and 4/5 of II and IIIA
*Depression, anxiety, apathy, withdrawal, delusions.
†This includes frank pain and/or dysaesthesia.
‡The typical appearance of the EEG in sporadic CJD consists of generalised triphasic 
periodic complexes at approximately 1/s. These may be occasionally seen in the late 
stages of vCJD.
§Tonsil biopsy is not recommended routinely, nor in cases with EEG appearances 
typical of sporadic CJD, but may be useful in suspect cases in which the clinical 
features are compatible with vCJD and MRI does not show bilateral pulvinar high 
signal.
¶Spongiform change and extensive prion protein deposition with florid plaques 
throughout the cerebrum and cerebellum.
EEG, electroencephalography; TSE, transmissible spongiform encephalopathy; vCJD, 
variant Creutzfeldt-Jakob disease. 
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The BPSU relies on the voluntary support of consultant paedi-
atricians: it does not provide complete ascertainment of cases 
and it is not always possible to obtain all the relevant data. When 
PIND cases are diagnosed they are not systematically followed 
up by the Study and follow-up has to be discontinued eventually 
in undiagnosed cases.
UK surveillance for prion diseases is carried out by the 
NCJDRSU, the team that first identified this new disease.1 The 
NCJDRSU relies on a network of neurologists, psychiatrists, 
neuropathologists and other clinical specialists who report 
adults with suspected vCJD. Because vCJD cases could be hidden 
among the multitude of rare neurodegenerative diseases of child-
hood a system of direct referral of suspected vCJD cases would 
not be reliable. The PIND Study therefore has to work via local 
paediatricians and other specialists to screen all the children in 
the UK with PIND.
Policy implications and future research
There has been increasing use of minimally invasive postmortem 
investigations in infants and children. Postmortem MRI can 
provide useful diagnostic information29–31 and may identify 
significant neuropathology in infants and children.32 Storage of 
blood and other relevant tissues for metabolic and/or genetic 
studies is very important; several PIND Study children have been 
diagnosed via the UK and Ireland Deciphering Developmental 
Disorders Study.33 Some children with undiagnosed PIND might 
be eligible for inclusion in the 100 000 Genomes Project.34 
Because of the recent advances in genetics undiagnosed children 
should be referred for an up-to-date opinion from a clinical 
geneticist.
The recent identification of the first patient with vCJD who 
was MV heterozygous at PRNP codon 129 reinforces the need 
for continued vCJD surveillance,3 particularly as a study of 
archived appendix samples from UK hospitals published in 2013 
indicated that approximately 1 in 2000 of the UK population is 
carrying abnormal prion protein in the gastrointestinal tract.35
Should more children with neurodegenerative diseases have 
autopsies? In this study, an underlying diagnosis had been made 
in the majority of children in whom investigations of their 
neurodegenerative diseases had been completed; in 99% of these 
1819 cases the diagnosis was reached before death without the 
need for brain biopsies or autopsies. Thus, the PIND Study does 
not provide evidence that autopsies should be performed more 
frequently in most children with neurodegenerative diseases 
meeting the Study criteria. However, if such children have been 
carefully investigated before death and are still undiagnosed 
there is a case for recommending postmortem studies. There 
are different considerations when trying to confirm or exclude 
vCJD, as this can only be done with certainty by neuropatho-
logical study. If postmortem studies of brain tissue were always 
performed after children died of undiagnosed neurodegenera-
tive diseases then vCJD would be detected and there would be 
no need for the PIND Study. However, the undiagnosed chil-
dren in the Study rarely underwent antemortem or postmortem 
pathological examination of brain tissue and this seems unlikely 
to change. Therefore, in the absence of an alternative validated 
vCJD screening test the PIND Study remains the only practical 
means of performing systematic surveillance for vCJD in UK 
children.
Author affiliations
1PIND Research Group, Addenbrooke’s Hospital, Cambridge, UK
2The National Creutzfeldt-Jakob Disease Research and Surveillance Unit, Western 
General Hospital, Edinburgh, UK
3Paediatric Neurology Department, Sheffield Children’s NHS Foundation Trust, 
Sheffield, UK
4Neurology Department, Great Ormond Street Hospital for Children NHS Foundation 
Trust, London, UK
5Institute of Child Health, Great Ormond Street Hospital for Children, London, UK
6Paediatric Neurology Department, Leeds General Infirmary, Leeds, UK
7Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, The 
Medical School, Newcastle upon Tyne, UK
8Paediatric Neurology Department, Oxford Children’s Hospital, John Radcliffe 
Hospital site, Oxford, UK
9Paediatric Neurology Department, Guy’s Hospital, London, UK
10Paediatric Neurology Department, Birmingham Children’s Hospital, Birmingham, UK
11Paediatric Neurosciences Research Group, Royal Hospital for Children and School 
of Medicine, University of Glasgow, Glasgow, UK
Acknowledgements Many thanks to the paediatricians who notify cases, to Mr 
Richard Lynn and Mr Jacob Avis of the BPSU and to the PIND Expert Group: PB, CdS, 
PG, MK, JL, RM, SP, MP, RR, EW, RW, Dr John Wilson and SZ.
Funding This report is based on independent research commissioned and funded 
by the National Institute for Health Research (NIHR) Policy Research Programme 
(’To Undertake Prospective Multisource Surveillance for all Cases of Progressive 
Intellectual and Neurological Deterioration Occurring in Children in the UK’ PR-
ST-1216-10001). 
Disclaimer The views expressed in this publication are those of the author(s) and 
not necessarily those of the NHS, the NIHR, the Department of Health, arm’s length 
bodies or other government departments. 
Competing interests None declared.
Patient consent Not required.
ethics approval NRES Committee East of England Cambridge Central.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
RefeRences
 1 Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in 
the UK. Lancet 1996;347:921–5.
 2 National Creutzfeldt-Jakob Disease Research and Surveillance website. latest NCJDSU 
CJD monthly statistics. http://www. cjd. ed. ac. uk/ sites/ default/ files/ figs. pdf (accessed 
31 Nov 2017).
 3 Mok T, Jaunmuktane Z, Joiner S, et al. Variant Creutzfeldt-Jakob disease in a patient 
with heterozygosity at prnp codon 129. N Engl J Med 2017;376:292–4.
 4 Bishop MT, Pennington C, Heath CA, et al. PRNP variation in UK sporadic and variant 
Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous 
polymorphism. BMC Med Genet 2009;10:146.
 5 NICE, 2006. Patient safety and reduction of risk of transmission of Creutzfeldt-
Jakob disease (CJD) via interventional procedures;22 https://www. nice. org. uk/ 
guidance/ ipg196/ resources/ patient- safety- and- reduction- of- risk- of- transmission- of- 
creutzfeldtjakob- disease- cjd- via- interventional- procedures- pdf- 1899863525353669.
 6 Seed CR, Hewitt PE, Dodd RY, et al. Creutzfeldt-Jakob disease and blood transfusion 
safety. Vox Sang 2018;113:220–31.
 7 Devereux G, Stellitano L, Verity CM, et al. Variations in neurodegenerative disease 
across the UK: findings from the national study of Progressive Intellectual and 
Neurological Deterioration (PIND). Arch Dis Child 2004;89:8–12.
 8 Verity C, Preece M. Surveillance for rare disorders by the BPSU. Arch Dis Child 
2002;87:269–71.
 9 Verity CM, Nicoll A, Will RG, et al. Variant Creutzfeldt-Jakob disease in UK children: a 
national surveillance study. Lancet 2000;356:1224–7.
 10 Royal College of Paediatrics and Child Health website. BPSU:Studies: progressive 
intellectual and neurological deterioration. https://www. rcpch. ac. uk/ pind (accessed 
31 Nov 2017).
 11 Office for National Statistics. Population Estimates by Ethnic Group (experimental), 
Comparison of mid-2010 Population Estimates by Ethnic Group against the 2011 
Census. file:// ukbia04sfsrv001. a04. dt21. svcs. hp. com/ users/ a04/ verityc/ comp aris onof 
mid2 010p eegs agai nst2 011c ensu sest imat esv2 tcm7 7320363. pdf (accessed 18 Aug 
2017).
 12 Verity C, Winstone AM, Stellitano L, et al. The epidemiology of progressive intellectual 
and neurological deterioration in childhood. Arch Dis Child 2010;95:361–4.
 o
n
 5 N
ovem
ber 2018 by guest. Protected by copyright.
http://adc.bmj.com/
Arch D
is Child: first published as 10.1136/archdischild-2018-315458 on 18 O
ctober 2018. Downloaded from
 
6 Verity C, et al. Arch Dis Child 2018;0:1–6. doi:10.1136/archdischild-2018-315458
Original article
 13 Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease 
with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed 
cases. AJNR Am J Neuroradiol 2003;24:1560–9.
 14 Burton JL, Underwood J. Clinical, educational, and epidemiological value of autopsy. 
Lancet 2007;369:1471–80.
 15 Shojania KG, Burton EC. The vanishing nonforensic autopsy. N Engl J Med 
2008;358:873–5.
 16 Turnbull A, Osborn M, Nicholas N. Hospital autopsy: Endangered or extinct? J Clin 
Pathol 2015;68:601–4.
 17 Turnbull A, Martin J, Osborn M. The death of autopsy? Lancet 2015;386:2141.
 18 Lewis C, Hill M, Arthurs OJ, et al. Factors affecting uptake of postmortem examination 
in the prenatal, perinatal and paediatric setting. BJOG 2018;125.
 19 Verity CM, Winstone AM, Stellitano L, et al. No clinical evidence of hidden vCJD in UK 
children. Arch Dis Child 2006;91:608–9.
 20 Heath CA, Cooper SA, Murray K, et al. Validation of diagnostic criteria for variant 
Creutzfeldt-Jakob disease. Ann Neurol 2010;67:761–70.
 21 Ironside JW, Head MW, Bell JE, et al. Laboratory diagnosis of variant Creutzfeldt-Jakob 
disease. Histopathology 2000;37:1–9.
 22 Moda F, Gambetti P, Notari S, et al. Prions in the urine of patients with variant 
Creutzfeldt-Jakob disease. N Engl J Med 2014;371:530–9.
 23 Concha-Marambio L, Pritzkow S, Moda F, et al. Detection of prions in blood from 
patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 2016;8:370ra183.
 24 Bougard D, Brandel JP, Bélondrade M, et al. Detection of prions in the plasma of 
presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci 
Transl Med 2016;8:370ra182.
 25 Verity CM, Winstone AM, Stellitano L, et al. The clinical presentation of mitochondrial diseases 
in children with progressive intellectual and neurological deterioration: a national, prospective, 
population-based study. Dev Med Child Neurol 2010;52:434–40.
 26 Smith NJ, Winstone AM, Stellitano L, et al. GM2 gangliosidosis in a UK study of 
children with progressive neurodegeneration: 73 cases reviewed. Dev Med Child 
Neurol 2012;54:176–82.
 27 Stellitano LA, Winstone AM, van der Knaap MS, et al. Leukodystrophies and genetic 
leukoencephalopathies in childhood: a national epidemiological study. Dev Med Child 
Neurol 2016;58:680–9.
 28 Winstone AM, Stellitano LA, Verity CM. Niemann-Pick type C as a cause of progressive 
intellectual and neurological deterioration in childhood. Dev Med Child Neurol 
2017;59:965–72.
 29 Thayyil S, Chandrasekaran M, Chitty LS, et al. Diagnostic accuracy of post-mortem 
magnetic resonance imaging in fetuses, children and adults: a systematic review. Eur J 
Radiol 2010;75:e142–8.
 30 Thayyil S, Sebire NJ, Chitty LS, et al. Post-mortem MRI versus conventional autopsy in 
fetuses and children: a prospective validation study. Lancet 2013;382:223–33.
 31 Addison S, Arthurs OJ, Thayyil S. Post-mortem MRI as an alternative to non-forensic 
autopsy in foetuses and children: from research into clinical practice. Br J Radiol 
2014;87:20130621.
 32 Arthurs OJ, Thayyil S, Pauliah SS, et al. Diagnostic accuracy and limitations of post-
mortem MRI for neurological abnormalities in fetuses and children. Clin Radiol  
2015;70:872–80.
 33 Wright CF, Fitzgerald TW, Jones WD, et al. Genetic diagnosis of developmental 
disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet 
2015;385:1305–14.
 34 Genomics England. The 100,000 Genomes Project. (accessed 22 Jan 2018).
 35 Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in 
human appendixes after bovine spongiform encephalopathy epizootic: large scale 
survey. BMJ 2013;347:f5675.
 o
n
 5 N
ovem
ber 2018 by guest. Protected by copyright.
http://adc.bmj.com/
Arch D
is Child: first published as 10.1136/archdischild-2018-315458 on 18 O
ctober 2018. Downloaded from
 
